A global biopharmaceutical company with fully integrated research, manufacturing and commercialization capabilities, Biominhai develops and transfers vaccines for infectious diseases and is the leading manufacturer of hepatitis B vaccine in China. The company has 9 marketed products, including 2 COVID-19 vaccines approved for emergency use, supported by 12 in-house R&D platforms.
暂无评论。
留下您的评分和评论